GoodRx Holdings (GDRX) Stock Forecast & Price Target

Compare

1,303 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GDRX Analyst Ratings

Moderate Buy

5 Buy

4 Hold

2 Sell

Based on 11 analysts giving stock ratings to

GoodRx

Holdings

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GDRX Stock 12 Month Forecast

Average Price Target

$4.75

▲(70.25% Upside)

Based on 11 Wall Street analysts offering 12 month price targets for GoodRx Holdings in the last 3 months. The average price target is $4.75 with a high forecast of $7.00 and a low forecast of $3.00. The average price target represents a 70.25% change from the last price of $2.79.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"$1","8":"$8","2.75":"$2.75","4.5":"$4.5","6.25":"$6.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$7.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$4.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,2.75,4.5,6.25,8],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.74,3.0676923076923077,3.3953846153846157,3.723076923076923,4.050769230769231,4.378461538461538,4.706153846153846,5.033846153846154,5.361538461538462,5.689230769230769,6.016923076923077,6.344615384615384,6.672307692307692,{"y":7,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.74,2.894615384615385,3.0492307692307694,3.203846153846154,3.3584615384615386,3.513076923076923,3.667692307692308,3.8223076923076924,3.976923076923077,4.131538461538462,4.286153846153846,4.440769230769231,4.595384615384615,{"y":4.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.74,2.7600000000000002,2.7800000000000002,2.8000000000000003,2.8200000000000003,2.8400000000000003,2.8600000000000003,2.88,2.9,2.92,2.94,2.96,2.98,{"y":3,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.95,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.65,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.77,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.98,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.43,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.64,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.82,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.96,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.53,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.3,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.03,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.37,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.74,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$7.00

Average Price Target$4.75

Lowest Price Target$3.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Glen Santangelo

Barclays

Sell

7.53%

Upside

Initiated

12/08/25

GoodRx initiated with an Underweight at BarclaysGoodRx initiated with an Underweight at Barclays

Allen Lutz

Bank of America Securities

$3.4→$3

Sell

7.53%

Upside

Reiterated

11/17/25

GoodRx price target lowered to $3 from $3.40 at BofAGoodRx price target lowered to $3 from $3.40 at BofA

Lisa Gill

J.P. Morgan

$6→$5

Buy

79.21%

Upside

Reiterated

11/11/25

GoodRx price target lowered to $5 from $6 at JPMorganGoodRx price target lowered to $5 from $6 at JPMorgan

Charles Rhyee

TD Cowen

$7→$6

Buy

115.05%

Upside

Reiterated

11/10/25

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (NASDAQ: PRAX) and GoodRx Holdings (NASDAQ: GDRX)We now est 2025/26 revs $793M/$811M, (from $798M/$849M). We est. 2025/26 adj. EBITDA of $268M/$285M (from $267M/$294M). While admittedly, 2026 outlook doesn't look great at this point, we believe shrs have overcorrected to the downside, w/ FCF yield at >13% at current levels. We lower DCF-based PT of $6, which implies shares can trade at ~8x EV/2026E EBITDA.

Craig Hettenbach

Morgan Stanley

Hold

79.21%

Upside

Reiterated

11/06/25

GoodRx Holdings: Balancing Challenges and Opportunities Amidst PTR Growth Concerns and Pharma Manufacturing Strength

Kevin Caliendo

UBS

$4.25→$4

Hold

43.37%

Upside

Reiterated

11/06/25

UBS Sticks to Its Hold Rating for GoodRx Holdings (GDRX)

Steven Valiquette

Mizuho Securities

$5→$4

Hold

43.37%

Upside

Reiterated

11/06/25

GoodRx price target lowered to $4 from $5 at MizuhoGoodRx price target lowered to $4 from $5 at Mizuho

Jailendra Singh

Truist Financial

―

Hold

―

Reiterated

11/06/25

GoodRx Holdings (GDRX) Receives a Hold from Truist Financial

Stan Berenshteyn

Wells Fargo

Buy

150.90%

Upside

Reiterated

11/05/25

Buy Rating for GoodRx Holdings: Strategic Initiatives and Growth Prospects Amid Challenges

Daniel Grosslight

Citi

$5.75

Buy

106.09%

Upside

Reiterated

10/21/25

Citi Reaffirms Their Buy Rating on GoodRx Holdings (GDRX)

Michael Cherny

Leerink Partners

―

Buy

―

Reiterated

10/02/25

We reiterate our Outperform rating on GDRX on this potential significant positive update.

George Hill

Deutsche Bank

$8→$6

Hold

115.05%

Upside

Reiterated

08/11/25

GoodRx price target lowered to $6 from $8 at Deutsche BankGoodRx price target lowered to $6 from $8 at Deutsche Bank

Eric Sheridan

Goldman Sachs

$5→$3.75

Hold

34.41%

Upside

Reiterated

08/11/25

Goldman Sachs Sticks to Their Hold Rating for GoodRx Holdings (GDRX)Goldman Sachs analyst Eric Sheridan lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $3.75 (from $5.00) while maintaining a Neutral rating.

John Ransom

Raymond James

$9→$5

Buy

79.21%

Upside

Reiterated

08/07/25

Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (NASDAQ: SRPT), GoodRx Holdings (NASDAQ: GDRX) and Enhabit, Inc (NYSE: EHAB)

Scott Schoenhaus

KeyBanc

Buy

115.05%

Upside

Reiterated

05/14/25

KeyBanc Remains a Buy on GoodRx Holdings (GDRX)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Glen Santangelo

Barclays

Sell

7.53%

Upside

Initiated

12/08/25

GoodRx initiated with an Underweight at BarclaysGoodRx initiated with an Underweight at Barclays

Allen Lutz

Bank of America Securities

$3.4→$3

Sell

7.53%

Upside

Reiterated

11/17/25

GoodRx price target lowered to $3 from $3.40 at BofAGoodRx price target lowered to $3 from $3.40 at BofA

Lisa Gill

J.P. Morgan

$6→$5

Buy

79.21%

Upside

Reiterated

11/11/25

GoodRx price target lowered to $5 from $6 at JPMorganGoodRx price target lowered to $5 from $6 at JPMorgan

Charles Rhyee

TD Cowen

$7→$6

Buy

115.05%

Upside

Reiterated

11/10/25

Craig Hettenbach

Morgan Stanley

Hold

79.21%

Upside

Reiterated

11/06/25

GoodRx Holdings: Balancing Challenges and Opportunities Amidst PTR Growth Concerns and Pharma Manufacturing Strength

Kevin Caliendo

UBS

$4.25→$4

Hold

43.37%

Upside

Reiterated

11/06/25

UBS Sticks to Its Hold Rating for GoodRx Holdings (GDRX)

Steven Valiquette

Mizuho Securities

$5→$4

Hold

43.37%

Upside

Reiterated

11/06/25

GoodRx price target lowered to $4 from $5 at MizuhoGoodRx price target lowered to $4 from $5 at Mizuho

Jailendra Singh

Truist Financial

―

Hold

―

Reiterated

11/06/25

GoodRx Holdings (GDRX) Receives a Hold from Truist Financial

Stan Berenshteyn

Wells Fargo

Buy

150.90%

Upside

Reiterated

11/05/25

Buy Rating for GoodRx Holdings: Strategic Initiatives and Growth Prospects Amid Challenges

Daniel Grosslight

Citi

$5.75

Buy

106.09%

Upside

Reiterated

10/21/25

Citi Reaffirms Their Buy Rating on GoodRx Holdings (GDRX)

Michael Cherny

Leerink Partners

―

Buy

―

Reiterated

10/02/25

We reiterate our Outperform rating on GDRX on this potential significant positive update.

George Hill

Deutsche Bank

$8→$6

Hold

115.05%

Upside

Reiterated

08/11/25

GoodRx price target lowered to $6 from $8 at Deutsche BankGoodRx price target lowered to $6 from $8 at Deutsche Bank

Eric Sheridan

Goldman Sachs

$5→$3.75

Hold

34.41%

Upside

Reiterated

08/11/25

John Ransom

Raymond James

$9→$5

Buy

79.21%

Upside

Reiterated

08/07/25

Analysts Conflicted on These Healthcare Names: Sarepta Therapeutics (NASDAQ: SRPT), GoodRx Holdings (NASDAQ: GDRX) and Enhabit, Inc (NYSE: EHAB)

Scott Schoenhaus

KeyBanc

Buy

115.05%

Upside

Reiterated

05/14/25

KeyBanc Remains a Buy on GoodRx Holdings (GDRX)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering GoodRx Holdings

1 Month

xxx

Success Rate

11/21 ratings generated profit

Average Return

+0.69%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 52.38% of your transactions generating a profit, with an average return of +0.69% per trade.

3 Months

xxx

Success Rate

14/19 ratings generated profit

Average Return

+9.87%

reiterated a xxx

rating 25 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 73.68% of your transactions generating a profit, with an average return of +9.87% per trade.

1 Year

Allen LutzBank of America Securities

Success Rate

19/19 ratings generated profit

Average Return

+33.70%

reiterated a sell rating 25 days ago

Copying Allen Lutz's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +33.70% per trade.

2 Years

xxx

Success Rate

19/19 ratings generated profit

Average Return

+41.22%

reiterated a xxx

rating 25 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +41.22% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GDRX Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, GDRX has received 8 Buy Ratings, 10 Hold Ratings, and 5 Sell Ratings. GDRX average Analyst price target in the past 3 months is 4.75.

Each month's total comprises the sum of three months' worth of ratings.

GDRX Financial Forecast

GDRX Earnings Forecast

Next quarter’s earnings estimate for GDRX is $0.09 with a range of $0.08 to $0.11. The previous quarter’s EPS was $0.08. GDRX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year GDRX has Performed in-line its overall industry.

GDRX Sales Forecast

Next quarter’s sales forecast for GDRX is $193.43M with a range of $191.00M to $200.70M. The previous quarter’s sales results were $196.03M. GDRX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year GDRX has Performed in-line its overall industry.

GDRX Stock Forecast FAQ

What is GDRX’s average 12-month price target, according to analysts?

Based on analyst ratings, GoodRx Holdings’s 12-month average price target is 4.75.

What is GDRX’s upside potential, based on the analysts’ average price target?

GoodRx Holdings has 70.25% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is GDRX a Buy, Sell or Hold?

GoodRx Holdings has a consensus rating of Moderate Buy which is based on 5 buy ratings, 4 hold ratings and 2 sell ratings.

What is GoodRx Holdings’s price target?

The average price target for GoodRx Holdings is 4.75. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $7.00 ,the lowest forecast is $3.00. The average price target represents 70.25% Increase from the current price of $2.79.

What do analysts say about GoodRx Holdings?

GoodRx Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of GDRX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

GoodRx Holdings (GDRX) Stock Forecast & Price Target

GDRX Analyst Ratings

GDRX Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering GoodRx Holdings

GDRX Analyst Recommendation Trends

GDRX Financial Forecast

GDRX Earnings Forecast

GDRX Sales Forecast

GDRX Stock Forecast FAQ

Detailed List of Analyst Forecasts